JP2010510976A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510976A5
JP2010510976A5 JP2009537744A JP2009537744A JP2010510976A5 JP 2010510976 A5 JP2010510976 A5 JP 2010510976A5 JP 2009537744 A JP2009537744 A JP 2009537744A JP 2009537744 A JP2009537744 A JP 2009537744A JP 2010510976 A5 JP2010510976 A5 JP 2010510976A5
Authority
JP
Japan
Prior art keywords
thiazolidin
hydroxy
benz
ylidene
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009537744A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510976A (ja
JP4669564B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/054752 external-priority patent/WO2008062376A2/en
Publication of JP2010510976A publication Critical patent/JP2010510976A/ja
Publication of JP2010510976A5 publication Critical patent/JP2010510976A5/ja
Application granted granted Critical
Publication of JP4669564B2 publication Critical patent/JP4669564B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009537744A 2006-11-23 2007-11-22 2−イミノ−チアゾリジン−4−オン誘導体の製造のための新規な方法 Active JP4669564B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006054409 2006-11-23
PCT/IB2007/054752 WO2008062376A2 (en) 2006-11-23 2007-11-22 New process for the preparation of 2-imino-thiazolidin-4-one derivatives

Publications (3)

Publication Number Publication Date
JP2010510976A JP2010510976A (ja) 2010-04-08
JP2010510976A5 true JP2010510976A5 (esLanguage) 2010-05-20
JP4669564B2 JP4669564B2 (ja) 2011-04-13

Family

ID=39316391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537744A Active JP4669564B2 (ja) 2006-11-23 2007-11-22 2−イミノ−チアゾリジン−4−オン誘導体の製造のための新規な方法

Country Status (13)

Country Link
US (1) US8263780B2 (esLanguage)
EP (2) EP2489662B1 (esLanguage)
JP (1) JP4669564B2 (esLanguage)
KR (1) KR101255879B1 (esLanguage)
CN (2) CN103087004A (esLanguage)
AU (1) AU2007323042B2 (esLanguage)
CA (1) CA2669069C (esLanguage)
DK (2) DK2489662T3 (esLanguage)
ES (2) ES2410793T3 (esLanguage)
IL (1) IL198847A (esLanguage)
MX (1) MX2009005048A (esLanguage)
TW (1) TWI460166B (esLanguage)
WO (1) WO2008062376A2 (esLanguage)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
CN100567275C (zh) 2003-11-21 2009-12-09 埃科特莱茵药品有限公司 作为免疫抑制剂的5-(苯基-(z)-亚基)-噻唑烷-4-酮衍生物
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
KR101718639B1 (ko) * 2008-03-17 2017-03-21 액테리온 파마슈티칼 리미티드 선별적 s1p₁ 수용체 작동약에 대한 투약 섭생
GB0819182D0 (en) 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms
US9340518B2 (en) * 2012-08-17 2016-05-17 Actelion Pharmaceuticals Ltd. Process for the preparation of (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropdxy)benzylidene)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one and intermediate used in said process
PL3256125T3 (pl) 2014-12-11 2022-05-09 Actelion Pharmaceuticals Ltd Schemat dawkowania ponesimodu, selektywnego agonisty receptora s1p1
MA41139A (fr) 2014-12-11 2017-10-17 Actelion Pharmaceuticals Ltd Combinaison pharmaceutique comportant un agoniste sélectif du récepteur sip1
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
US11220488B2 (en) 2017-09-19 2022-01-11 Teva Pharmaceuticals International Gmbh Crystalline polymorph of Ponesimod
US11013723B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms of a thiazolidinone compound, compositions and methods of use thereof
US11186556B1 (en) 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
US11014940B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Thiazolidinone and oxazolidinone compounds and formulations
US11014897B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
US20220315545A1 (en) * 2019-07-10 2022-10-06 Bayer Aktiengesellschaft Process of preparing 2-(phenylimino)-1,3-thiazolidin-4-ones
EP3997076A1 (de) * 2019-07-10 2022-05-18 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-1,3-thiazolidin-4-onen
CA3156298A1 (en) 2019-10-31 2021-05-06 Laetitia POUZOL Combination of a cxcr7 antagonist with an s1p1 receptor modulator
KR20200019639A (ko) 2020-01-30 2020-02-24 전대연 만남의 스마트 도착시스템
BR112022014704A2 (pt) * 2020-02-18 2022-10-11 Bayer Ag Processo para a preparação de 2-(fenilimino)-3-alquil-1,3-tiazolidin-4-onas
WO2023022896A1 (en) 2021-08-17 2023-02-23 Teva Czech Industries S.R.O Polymorphs of ponesimod
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator
WO2023152691A1 (en) * 2022-02-10 2023-08-17 Metrochem Api Pvt Ltd Process for the preparation of ponesimod and its intermediates thereof
CN117924210A (zh) * 2024-01-22 2024-04-26 赣南师范大学 一种2-亚氨基噻唑烷-4-酮类化合物的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077402A (en) * 1954-12-06 1963-02-12 Polaroid Corp Photographic color processes, products, and compositions
NL270002A (esLanguage) 1960-10-08
OA03835A (fr) * 1970-07-17 1971-12-24 Rhone Poulenc Sa Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
DE69123738T2 (de) 1990-04-27 1997-07-03 Orion-Yhtymae Oy, Espoo Pharmakologisch aktive catecholderivate
TW221689B (esLanguage) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
WO1994019335A1 (en) * 1993-02-26 1994-09-01 Otsuka Pharmaceutical Co., Ltd. Thiazole or imidazole derivatives as maillard reaction inhibitors
KR960022486A (ko) 1994-12-29 1996-07-18 김준웅 신규 티아졸리딘-4-온 유도체
US6353006B1 (en) * 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
DE60038687T2 (de) 1999-09-14 2009-05-28 Shionogi & Co., Ltd. 2-imino-1,3-thiazin-derivate
PT1142885E (pt) * 1999-11-12 2007-02-28 Fujimoto Brothers Co Ltd Derivados de 2-(n-cianoimino)tiazolidin-4-ona
US20050019825A9 (en) * 2002-03-15 2005-01-27 Qing Dong Common ligand mimics: pseudothiohydantoins
RS115904A (sr) 2002-07-10 2006-12-15 Applied Research Systems Ars Holding N.V. Derivati benzena fuzionisani sa azolidinon vinilom
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
CA2507256A1 (en) * 2002-11-22 2004-06-10 Smithkline Beecham Corporation Thiazolidine compounds in the treatment of anemic conditions
US20040167192A1 (en) * 2003-01-16 2004-08-26 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
CN100567275C (zh) * 2003-11-21 2009-12-09 埃科特莱茵药品有限公司 作为免疫抑制剂的5-(苯基-(z)-亚基)-噻唑烷-4-酮衍生物
JP2007523957A (ja) * 2004-02-25 2007-08-23 スミスクライン・ビーチャム・コーポレイション 新規化学化合物
WO2006094233A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. N,n'-dicyclic isothiourea sirtuin modulators
KR101718639B1 (ko) * 2008-03-17 2017-03-21 액테리온 파마슈티칼 리미티드 선별적 s1p₁ 수용체 작동약에 대한 투약 섭생
GB0819182D0 (en) * 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms

Similar Documents

Publication Publication Date Title
JP2010510976A5 (esLanguage)
JP4669564B2 (ja) 2−イミノ−チアゾリジン−4−オン誘導体の製造のための新規な方法
JP2010513494A5 (esLanguage)
JP2007523139A5 (esLanguage)
JP2011006405A5 (ja) 化合物
JP2012526842A5 (esLanguage)
JP2009515872A5 (esLanguage)
JP2010515731A5 (esLanguage)
JP2009523146A5 (esLanguage)
JP2008511601A5 (esLanguage)
JP2010531876A5 (esLanguage)
JP2009527501A5 (esLanguage)
JP2008538381A5 (esLanguage)
JP2013535220A5 (esLanguage)
JP2018135343A5 (esLanguage)
JP2005289914A5 (esLanguage)
JP2007519721A5 (esLanguage)
JP2009544663A5 (esLanguage)
JP2010534246A5 (esLanguage)
JP2013515755A5 (esLanguage)
JP2012503653A5 (esLanguage)
JP2008517965A5 (esLanguage)
JP2012509262A5 (esLanguage)
JP2018115129A5 (esLanguage)
JP2006528215A5 (esLanguage)